Target intelligence / Profile preview

E3 ubiquitin-protein ligase ring finger protein 133 (RNF133)

Target
RNF133
Molecular classification
Enzyme, E3 ubiquitin ligase, RING finger protein, Membrane-associated protein
01

Overview

E3 ubiquitin-protein ligase ring finger protein 133 (RNF133) is an enzyme that catalyzes the transfer of ubiquitin from E2 conjugating enzymes to substrate proteins. It is specifically expressed in the testis and is essential for the proper morphological development and motility of sperm cells during spermiogenesis. RNF133 is a membrane-associated protein localized to the endoplasmic reticulum and facilitates selective protein degradation as part of the ER-associated degradation pathway. Loss of RNF133 activity in mice leads to severely reduced sperm fertility, abnormal sperm morphology, and impaired motility, highlighting its critical physiological role in male reproductive biology[1][2][4][5][7]. RNF133 is a member of the RING finger protein family of E3 ligases and interacts with UBE2J1, an ER-localized E2 ubiquitin-conjugating enzyme[1][2][5]. Currently, there are no drugs, established biomarkers, or clinical safety concerns directly linked to RNF133, though its essential role in spermatogenesis makes it a candidate for research in male fertility and contraceptive development.

Other names
RING finger protein 133RING-type E3 ubiquitin transferase RNF133E3 ubiquitin-protein ligase RNF133RNF133
02

Mechanism of action

not applicable

03

Biological functions

UbiquitinationProtein degradationSpermiogenesisER-associated degradation (ERAD)Protein homeostasis
04

Disease associations

Male infertilityDevelopmental encephalopathy
05

Safety considerations

Potential impact on fertilityTherapeutic targeting challenge

Beyond the preview

Go deeper on E3 ubiquitin-protein ligase ring finger protein 133 (RNF133).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E3 ubiquitin-protein ligase ring finger protein 133 (RNF133).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call